FindTrial
Sign In

Reliminary study for benign and malignant soft tissue mass prediction based on MRI features of radiomics

Reliminary study for benign and malignant soft tissue mass prediction based on MRI features of radiomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032572
Enrollment
Unknown
Registered
2020-05-02
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft tissue mass

Interventions

Gold Standard:Pathologic diagnosis.
Index test:MRI&#32
features&#32
of&#32
radiomics

Sponsors

The University of Hong Kong-Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing MRI before ultrasound-guided puncture or open biopsy; 2. MRI sequence including complete axial T2WI, DWI and T1WI enhancements.

Exclusion criteria

Exclusion criteria: 1. Have undergone a biopsy within 6 months before the MRI examination; 2. Participants who have received relevant treatment of soft tissue tumor before MRI examination; 3. Metal prosthesis in corresponding area; 4. Has motion artifacts; 5. MRI sequence is incomplete as described above; 6. Not confirmed by pathology.

Design outcomes

Primary

MeasureTime frame
Radiomics;Sensitivity;Specificity;Accuracy;—

Countries

China

Contacts

Public ContactZhendong Luo

The University of Hong Kong-Shenzhen Hospital

lzhend@163.com+86 15986815436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026